BOLOGNA ed altri: "Norme per il sostegno della ricerca e della produzione dei farmaci orfani e della cura delle malattie rare " (1317)

This procedure concerns rules to support the research and production of orphan drugs, which are medicines for rare diseases. It aims to improve access to treatments for patients with uncommon conditions. It affects patients with rare diseases, pharmaceutical companies involved in orphan drug development, and research institutions. The goal is to foster innovation and availability of these vital medicines.